Skip to main content
Caplight Logo









Releaf Dispensary Ltd

Releaf Dispensary Ltd

Private
LondonHealthcare & Life Scienceshttps://releaf.co.uk/

Last Round

Early Funding

Mar 22, 2023

Total Funding Raised

$1.84M

Company Overview

Releaf Dispensary Ltd is a medical cannabis clinic and health technology company that provides consultations and access to cannabis-based prescription medicines in the United Kingdom.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Patient Engagement, Subscription Commerce, Mental Health

Business Model

B2C

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

medical cannabistelemedicinecannabis clinicprescription managementdigital health platformmedical cannabis cardonline consultationsubscription pharmacyweed deliverycannabis prescriptionlegal cannabis accesschronic pain treatmenttelehealthe-health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Releaf Dispensary Ltd Comparables

Compare Releaf Dispensary Ltd with similar companies based on industry and business-model similarity.

Releaf Dispensary Ltd comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Alternaleaf
92%
Lyphe Group
89%
Montu
86%

Releaf Dispensary Ltd Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingMar 22, 2023

Key People

Founding team and executive leadership

Oliver Soar

Co-founder & CTO

Founding Team

Tim Kirby

Chief Executive Officer

Executive Team

Dawn Wood

Chief Operating Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 24, 2026

    Grew 16% QoQ, from 147 to 170 employees.

  • Mar 23, 2026

    Grew 17% QoQ, from 140 to 164 employees.

Releaf Dispensary Ltd Filings

Explore SEC and related filing metadata, where available.

Releaf Dispensary Ltd filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Releaf Dispensary Ltd's valuation, stock price, and market status.

Is Releaf Dispensary Ltd a public or private company?

Releaf Dispensary Ltd is a private company.

What is the current stock price of Releaf Dispensary Ltd?

Releaf Dispensary Ltd is a private company with no public stock price. No recent secondary market data is available.

How much is Releaf Dispensary Ltd worth (valuation)?

Valuation information for Releaf Dispensary Ltd is not publicly available.

Can I buy Releaf Dispensary Ltd stock?

Releaf Dispensary Ltd shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Releaf Dispensary Ltd's last funding round?

Releaf Dispensary Ltd's most recent funding round was Early Funding on March 22, 2023.

Who are the main investors in Releaf Dispensary Ltd?

Investor information for Releaf Dispensary Ltd is not publicly disclosed.

Will Releaf Dispensary Ltd IPO soon?

No public IPO plans have been announced for Releaf Dispensary Ltd.

How can I track Releaf Dispensary Ltd secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Releaf Dispensary Ltd's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range63
Year Founded2022
Last FundingMar 22, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?